It detects "CD markers" (Clusters of Differentiation). CD34: Signals a primitive, immature cell. CD19/CD20: Confirms a B-cell lineage. CD13/CD33: Points toward myeloid involvement. The Synthesis: A Final Diagnosis
Cells are suspended in fluid and tagged with fluorescent antibodies.
This is where the story shifts from "how it looks" to "who it is." Flow cytometry acts as a high-speed interrogator for cells. Flow Cytometry in Neoplastic Hematology Morphol...
Morphology can suggest a lineage, but it cannot always prove it. Two cells might look identical but behave like total strangers. The Molecular Fingerprint (Flow Cytometry)
This is for informational purposes only. For medical advice or diagnosis, consult a professional. AI responses may include mistakes. Learn more It detects "CD markers" (Clusters of Differentiation)
Everything begins with a blood smear or bone marrow aspirate. Under the microscope, a pathologist looks for "blasts"—cells that have lost their way. Are the cells abnormally large? The Nucleus: Is the chromatin clumped or fine? The Clues: Presence of Auer rods or specific granules.
The microscopic world of hematology is often a battle between what we see and what is actually there. In the diagnosis of neoplastic diseases, the "story" is one of collaboration between traditional morphology and the high-tech precision of flow cytometry. The Visual Clues (Morphology) CD13/CD33: Points toward myeloid involvement
📍 Morphology provides the context , while Flow Cytometry provides the certainty . Together, they allow doctors to distinguish between a treatable condition and an aggressive malignancy, ensuring the patient gets the specific "key" (treatment) for their "lock" (disease).